Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-23

FDA Approved: METHIMAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for methimazole from Rising Pharma Holdings, expanding the availability of this generic treatment for hyperthyroidis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methimazole (Methimazole)

Snippet

SUPPL AP for METHIMAZOLE (METHIMAZOLE)